Results - Announcements
Astec Lifesciences Ltd share price declined by 1.23% to Rs 664.3 after the company's net profit jumped 99.89% to Rs 37.4 crore, while revenue from operations slipped 13.81% to Rs 72.02 crore in Q3FY26 over Q2FY26.
The market capitalization of Pesticides & Agrochemicals industry group stocks on BSE stood at Rs 1.83 lakh crore, tumbling by 29.41%. It has reduced by 10.12% over last one week and tumbled 24.50% in last one month while the market capitalization of Astec Lifesciences Ltd has eased by 6.46% and 0.97% in the same period respectively.
Profit before tax (PBT) of Astec Lifesciences Ltd stood at Rs 37.43 crore in Q3 FY26, expanding by 53.34% year-on-year, and jumping 99.73% quarter-on-quarter. EBITDA came in at Rs 20 crore, surging by 161.33% YoY and rallying 1368.35% sequentially.
Total expenses inched up 8.07% to Rs 102.99 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 56.28 crore, registering a fall of 26.26% YoY, while employee benefits expense was at Rs 15.11 crore, registering a marginal contraction of 5.56% YoY.
For the TTM ended FY26, revenue from operations advanced 17.53% to Rs 448.15 crore, while net profit tumbled by 39.96% to Rs 80.88 crore, compared to previous TTM. EBITDA saw a sharp decline of 7163% to Rs 9.6 crore, and PBT collapsed by 42.55% to Rs 81.0 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 80.71 crore in FY26, as against Rs 8.4 crore in FY25.
Astec Lifesciences Ltd softened by 3.47% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.52% during the same period.